Associate Vice President，Assistant General Patent Counsel, Asia Regional Patent Counsel.｜助理副总裁、亚太地区知识产权负责人

Eli Lilly｜礼来

至今已从事18余年医药创新知识产权工作。在加入礼来公司之前，曾在安斯泰来制药集团东京总部担任过多个生物制品项目的全球知识产权负责人。曾于2014年接受日本发明促进协会邀请，撰写了一部比较中日生物及化学专利保护实务差异的二十余万字的专利实务专著。何博士拥有中国临床医学本科，药理学硕士以及日本生物学博士学位。

She has been engaged in pharmaceutical innovation IP work for more than 18 years. Prior to joining Lilly, she served as a global IP responsible manager for multiple biologics’ projects at Tokyo headquarters of Astellas Pharmaceuticals. In 2014, she was invited byJapan Institute of Promoting Invention and Innovation (JIII)to write and publish a patent practice monograph of more than 200,000 words comparing the differences between Chinese and Japanese biological and chemical patent protection practices. Dr. He obtained a Bachelor of Clinical Medicineanda Master of Pharmacology in China and a Ph.D. of bioscience in Japan.